Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2024-04.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Factors Associated with Insulin Resistance in a Middle-Aged Non-Obese Rural Population: The Chungju Metabolic Disease Cohort (CMC) Study
Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Epidemiol Health > Volume 33; 2011 > Article
Original Article
 Factors Associated with Insulin Resistance in a Middle-Aged Non-Obese Rural Population: The Chungju Metabolic Disease Cohort (CMC) Study
Sun Young Lim1,2, Hee Sung Ha3, Hyuk-Sang Kwon4, Jin-Hee Lee2, Hyeon Woo Yim1,3, Kun-Ho Yoon2,4, Won-Chul Lee1,3, Ho-Young Son4, Yong-Moon Park1,3
Epidemiol Health 2011;33:e2011009.
DOI: https://doi.org/10.4178/epih/e2011009
Published online: September 26, 2011

1Graduate School of Public Health, The Catholic University of Korea, Seoul, Korea.

2The Catholic Institute of Ubiquitous Healthcare, The Catholic University of Korea, Seoul, Korea.

3Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

4Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Correspondence: Yong-Moon Park, MD, PhD, MS. Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701 Korea. Tel: +82-2-2258-7369, Fax: +82-2-532-3820, markYMpark@gmail.com
• Received: December 28, 2009   • Accepted: August 29, 2011

© 2011, Korean Society of Epidemiology

This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 14,832 Views
  • 90 Download
  • 4 Crossref
Full Article

Download PDF Download PDF

  • OBJECTIVES
    We aimed to determine the characteristics affecting insulin resistance in non-obese middle-aged adults in a rural community.
  • METHODS
    A total of 1,270 non-diabetic adults aged between 40 and 64 years old with body mass index (BMI) less than 25 kg/m2 were analyzed. Subjects with insulin resistance were defined as those who had the highest quartile value of the homeostasis model assessment of insulin resistance (HOMA-IR) in a non-diabetic population.
  • RESULTS
    A total of 217 subjects (20.6%) had insulin resistance. Prevalence of metabolic syndrome was significantly higher in insulin-resistant subjects in both men (29.3% vs. 10.3%) and women (34.1% vs. 15.6%). Among metabolic syndrome components, elevated waist circumference and elevated triglyceride were higher in insulin-resistant subjects in both genders. After being controlled for socioeconomic status and lifestyle related covariates, the association between insulin resistance and BMI was statistically significant in the category of 23.0-24.9 kg/m2 in men (adjusted OR, 4.63; 95% confidence interval [95% CI], 1.77-12.15) using the category of 18.5-20.9 kg/m2 as a reference. In addition, the association between insulin resistance and abdominal obesity was statistically significant only for men (adjusted OR, 2.57; 95% CI, 1.29-5.11).
  • CONCLUSION
    Insulin resistance appears to be highly associated with high BMI and abdominal obesity, even in non-obese, non-diabetic middle-aged men.
  • Keywords: Abdominal obesity, BMI, Insulin resistance
Obesity is a risk factor for various types of metabolic disease including type 2 diabetes and hypertension [1-3], and it has been considered as a major health issue in many countries [4]. One of the diagnostic indicators for obesity, body mass index (BMI), has a simplified measurement method. In addition, it has been known as a useful tool for predicting risks of developing various types of cardiovascular disease [5]. However, a BMI-based diagnosis of obesity cannot include all the scope of obesity. For instance, in all the patients who were diagnosed as obese, there was a lack of the collection of metabolic risk factors associated with cardiovascular disease. It has also been reported that the people in the non-obesity range did not always show healthy metabolic status [6].
Of these concepts, patients who were not apparently obese, i.e., had a normal profile based on BMI criteria but had obesity-related metabolic abnormalities, were defined as "Metabolically Obese Normal Weight (MONW)" by Ruderman et al. [7]. It was hypothesized that these subjects showed hyperinsulinemia or insulin resistance, acquired a metabolically obese status and had a higher degree of risk of developing cardiovascular disease [8]. In the MONW group, as compared with the control group, the incidence of abdominal obesity and visceral fat was relatively higher. With the presentation of hypercholesterolemia, low high-density lipoproteinemia, hypertriglyceridemia and high blood pressure, risks of developing cardiovascular disease have been reported to be relatively higher [9,10]. In addition, a prospective cohort study shows that higher risks of developing type 2 diabetes and cardiovascular disease have been found in the MONW group as compared with subjects who were metabolically healthy. These results were also shown to be relatively higher following a comparison with obese subjects who were metabolically healthy [11].
Through the active identification, with the use of such interventions as diet, exercise therapy and drug treatments, the necessity for the delay of disease progression has been proposed [12]. For the appropriate management of these patients, their characteristics should first be clarified. In Korea, however, there are few studies about these issues. Other than small sample sizes in most of the pre-existing studies, there were also limitations that socioeconomic status and lifestyle-related characteristics were not considered.
The purpose of this study was to determine the characteristics of clinical, socioeconomic, and lifestyle features affecting the insulin resistance in non-obese middle-aged adults who were residing in a rural community.
Subjects
The current study was conducted in adults aged 40 years or older who were residing in rural districts of Chungju area between 2005 and 2006 from February to April in each year. Subject areas were stratified into 29 rural health subcenters and health care posts. Using a stratified random cluster sampling in which towns belonging to each district were classified as a cluster, 166 towns were selected and 6,388 subjects participated in the current study [13-15]. Of them, based on the BMI, 1,679 non-obese (18.5-24.9 kg/m2) adults aged between 40 and 64 years (males: 761 and females: 918) were enrolled in the current study. After excluding 409 subjects (those with a past history of cardiovascular diseases, diabetes mellitus or hypertension, and those whose fasting glucose and fasting insulin were dropped out), 1,270 subjects (males: 598 and females: 672) were finally selected as a study population. The current study was approved by The Institutional Review Board (IRB) of The Catholic University of Korea, the Kangnam St. Mary's Hospital.
Measurements
A questionnaire survey was performed to examine lifestyle-related characteristics such as smoking, drinking and exercise habit. The status of smoking and drinking alcohol were examined. The type of exercise, the mean frequency of exercise and exercise time were examined. Sociodemographic variables include the educational status, occupation, the total monthly income, and living with spouse of the subjects. Eating over 20 kinds of the food items including meat, fish, vegetable, fruit and rice in a day was defined as a balanced diet [16].
Using the standardized methods, the height, weight, and waist and the hip were measured. The height, waist and hip were measured at a unit of 0.1 cm. The weight was measured at a unit of 0.1 kg. BMI was calculated using the formula weight (kg)/height (m2). The systolic blood pressure and diastolic blood pressure were measured using a sphygmomanometer in a sitting position after a more than 10-minute stabilization prior to blood sampling. In the right upper arm, the blood pressure was measured twice. Then, in cases in which the difference in the diastolic pressures was smaller than 5 mmHg, the average value of two measurements was obtained.
Prior to blood sampling, all subjects were fasted over 12 hours and blood analysis was performed in a central laboratory. Total serum cholesterol and triglyceride were measured using an enzymatic calorimetric test. High-density lipoprotein (HDL) cholesterol was measured using a selective inhibition method, and low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald formula [17]. Following the blood sampling, a sodium fluoride tube was used to store and transfer fasting glucose. It was measured using the hexokinase method. Fasting serum insulin was measured using a Radiommunoassay kit (Dainabot, Japan).
In the current study, of those whose BMI was within a normal range (18.5-24.9 kg/m2), to define the group where there was a insulin resistance, insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR). Of 6,388 adults aged 40 years or older who participated in the current study, excluding patients with diabetes mellitus, 5,779 were used to establish a critical point which corresponds to the highest quartile number of HOMA-IR in each year (2005, 1.69; 2006, 1.74). Of subjects who were enrolled in the current study, those who corresponded to more than a critical point were considered to have an insulin resistance. The formula for calculating HOMA-IR was as follows:
(HOMA-IR=fasting insulin (µU/mL)×fasting glucose (mmol/L)/22.5) [18].
A definition of metabolic syndrome was made based on the criteria of modified NCEP-ATP III (Third report of National Cholesterol Education Program Expert panel on detection, evaluation and treatment of high blood cholesterol in adults-Adults Treatment Panel III, 2001) [19] using the criteria of abdominal obesity based on the Korean Society for the Study of Obesity diagnostic criteria of male ≥90 cm and female ≥85 cm [20].
Statistical analysis
To compare the characteristics between insulin-resistant subjects and the other group by gender, a chi-square test for categorical variables and student's t-test for continuous variables were applied. For parameters showing non-normal distributions (triglycerides, fasting glucose, fasting insulin, and HOMA-IR), Wilcoxon rank sum test was performed. To examine the factors associated with insulin resistance in the non-obese group, a multiple logistic regression was performed by gender. Variables of p-value <0.25 in the univariate test were selected as candidates for the multivariate model along with age. All two-tailed p-values of 0.05 were regarded as indicating statistical significance. All the statistical analyses were performed using SAS version 9.1 (SAS Inc., Cary, NC, USA).
A comparison of the general and lifestyle-related characteristics between the subjects with insulin resistance and without insulin resistance
A total of 82 men (13.7%) and 135 women (20.1%) were insulin-resistant subjects. The proportion of insulin-resistant subjects was higher in subjects with over nine years of education (p=0.042) for men, and lower in farmers for women (p=0.041) (Table 1).
A comparison of clinical characteristics between the subjects with insulin resistance and without insulin resistance
BMI, waist circumference, total cholesterol, total cholesterol to high-density lipoprotein cholesterol ratio, fasting glucose, fasting insulin, and HOMA-IR were significantly higher in insulin-resistant subjects for both men and women. HDL cholesterol was significantly lower in insulin-resistant subjects for both men and women. Triglyceride, LDL cholesterol and triglyceride to HDL cholesterol ratio were significantly higher in insulin-resistant subjects only for women (Table 2).
A comparison of metabolic syndrome and its components between insulin-resistant subjects and others by gender
A comparison was made for the prevalence of metabolic syndrome and its components (modified NCEP-ATP III criteria) by gender. The prevalence of metabolic syndrome was about three times higher for men and over two times higher for women in the insulin-resistant subjects compared to the non-insulin-resistant subjects. Of various categories of metabolic syndrome, high waist circumference, high triglycerides, and high fasting plasma glucose showed a significantly higher prevalence in the insulin-resistant subjects in both genders (Table 3).
Factors associated with insulin resistance in the non-obese population
After being controlled for all other covariates, the association between insulin resistance and BMI was statistically significant in the category of 23.0-24.9 kg/m2 in men (adjusted OR, 4.63; 95% confidence interval [95% CI], 1.77-12.15) using the category of 18.5-20.9 kg/m2 as a reference. The association between insulin resistance and abdominal obesity was statistically significant only for men (adjusted OR, 2.57; 95% CI, 1.29-5.11) (Table 4).
In the present study, we demonstrated that high BMI and abdominal obesity were associated with insulin resistance in non-obese middle-aged men living in rural areas. Insulin resistance was also associated with higher prevalence of metabolic syndrome and its components such as elevated waist circumference and elevated triglyceride in both genders. It is well known that insulin resistance increases the risk for type 2 diabetes and cardiovascular disease, even for those within the normal BMI range [11]. This finding could be more significant in Asians who are generally less obese but have more body fat than Caucasians, which renders them to have more obesity-related risks for cardiovascular diseases with similar BMI [21].
Waist circumference was found to be significantly higher in insulin-resistant subjects not only according to the criteria of abdominal obesity based on the Korean Society for the Study of Obesity, but also the criteria of abdominal obesity based on the Asia-Pacific diagnostic criteria of male ≥90 cm and female ≥80 cm [22]. Central obesity has been mentioned as one of the major characteristics observed in the MONW group [12], and it has also been known to be correlated with insulin resistance [23,24]. The relationship between central obesity and insulin resistance could be explained based on the metabolism of free fatty acids or other adipocytokines (TNF-α, IL-6, adiponectin) released from the visceral fat [25]. The abdominal obesity and visceral fat were reportedly increased in insulin-resistant subjects [9].
We noted that high BMI and abdominal obesity were associated with insulin resistance only in non-obese men. This gender-specific discrepancy in the development of metabolic abnormalities has been explained by sex differences in associations between inflammatory markers [26] and endogenous sex hormones [27] based on the data from Caucasian studies. However, well-designed prospective cohort studies are warranted to elucidate this phenomenon in non-obese Asians.
In this study, we found that metabolic syndrome, a potent risk factor for cardiovascular disease [28], had a prevalence that was more than two times higher in insulin-resistant subjects. In addition to elevated waist circumference, it was typically observed that elevated triglyceride was significantly higher in insulin-resistant subjects in both genders. In the previous studies conducted in western countries [29,30] cholesterol level was significantly higher in insulin-resistant subjects. On the other hand, a study of non-diabetic Korean adults shows that insulin resistance was associated with high triglycerides [31]. In addition, a Japanese study shows that triglyceride level was uniquely higher in insulin-resistant subjects, suggesting that the increased level of triglyceride would play a role in association with insulin resistance in the non-obese Asian people [10].
In the current study, to define insulin-resistant subjects, an insulin resistance was assessed with the application of HOMA-IR. This was used to presume the functions of beta cells as well as insulin sensitivity through fasting insulin and fasting glucose. It is also known to be highly correlated with insulin resistance measured with the hyperinsulinaemic clamp method [18]. Accordingly, it has widely been used as a tool for measuring insulin resistance in a large-scale community-based epidemiological study. Other methods to define the insulin resistance include measuring visceral fat areas [32,33] and using NCEP-ATP III metabolic syndrome diagnostic criteria [11,34]. Despite the differences in defining insulin resistance observed in each study, in regard to the characteristics of insulin resistant subjects, consistent results have been mostly proposed [9].
The current study has limitations that should be considered. The areas of visceral fat were not measured although they were a valid estimator of the abdominal obesity, which was mentioned as one of the major characteristics of the non-obese group with an insulin resistance. Due to a cross-sectional design, the current study has difficulty determining the causality in regard to the observed relationship between the factors and insulin resistance. In such a condition that there are few Korean studies, however, the results of the current study could be considered to be significant.
In conclusion, in middle-aged adults who were apparently non-obese, insulin resistance defined by highest quartile of HOMA-IR was associated with high BMI and abdominal obesity for men. Further prospective studies are warranted to clarify risk factors, which is essential for detecting insulin resistant subjects and performing the appropriate interventions for them.
This study was supported by the grants from the "2003-2005 Korea Health Promotion Research Program" of the Ministry of Health and Welfare, Republic of Korea.
We would like to thank the personnel in the Chungju public health center for recruiting the participants as well as for collecting the data for this study.

The authors have no conflicts of interest to declare for this study.

This article is available from: http://e-epih.org/.

  • 1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105. 10511607.ArticlePubMed
  • 2. Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, et al. Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002;26:1232-1238. 12187401.ArticlePubMed
  • 3. Oh SW, Shin SA, Yun YH, Yoo T, Huh BY. Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res 2004;12:2031-2040. 15687405.ArticlePubMed
  • 4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79. 12503980.ArticlePubMed
  • 5. Sung KC, Ryu S, Reaven GM. Relationship between obesity and several cardiovascular disease risk factors in apparently healthy Korean individuals: comparison of body mass index and waist circumference. Metabolism 2007;56:297-303. 17292715.ArticlePubMed
  • 6. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575. 15181025.ArticlePubMed
  • 7. Ruderman NB, Schneider SH, Berchtold P. The "metabolically-obese," normal-weight individual. Am J Clin Nutr 1981;34:1617-1621. 7270486.ArticlePubMed
  • 8. Ruderman NB, Berchtold P, Schneider S. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 1982;6:151-157. 6749721.PubMed
  • 9. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12. 17332780.ArticlePubMed
  • 10. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003;26:2341-2344. 12882859.ArticlePubMed
  • 11. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912. 16735483.ArticlePubMed
  • 12. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713. 9588440.ArticlePubMed
  • 13. Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, et al. Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. Korean J Intern Med 2005;20:310-316. 16491829.ArticlePubMedPMC
  • 14. Lee HS, Park YM, Kwon HS, Lee JH, Park YJ, Lim SY, et al. Prevalence, awareness, treatment, and control of hypertension among people over 40 years old in a rural area of South Korea: The Chungju Metabolic Disease Cohort (CMC) Study. Clin Exp Hypertens 2010;32:166-178. 20504124.ArticlePubMed
  • 15. Park YM, Kwon HS, Lim SY, Lee JH, Yoon KH, Son HY, et al. Optimal waist circumference cutoff value reflecting insulin resistance as a diagnostic criterion of metabolic syndrome in a nondiabetic Korean population aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC) study. Yonsei Med J 2010;51:511-518. 20499415.ArticlePubMedPMC
  • 16. Korea Health Industry Development Institute. Dietary guidelines for better nutrition. 2000. Seoul: Korea Health Industry Development Institute; (Korean).
  • 17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502. 4337382.ArticlePubMed
  • 18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. 3899825.ArticlePubMed
  • 19. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497. 11368702.ArticlePubMed
  • 20. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes 2006;15:1-9 (Korean).
  • 21. Iwao N, Iwao S, Muller DC, Koda M, Ando F, Shimokata H, et al. Differences in the relationship between lipid CHD risk factors and body composition in Caucasians and Japanese. Int J Obes (Lond) 2005;29:228-235. 15570315.ArticlePubMed
  • 22. Bassett J. International Diabetes Institute. World Health Organization. Regional Office for the Western Pacific. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. Australia: Health Communications Australia.
  • 23. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-E948. 10780952.ArticlePubMed
  • 24. Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) 2004;1:12. 15530168.ArticlePubMedPMC
  • 25. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007;17:319-326. 17110092.ArticlePubMed
  • 26. Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007;30:854-860. 17392546.ArticlePubMed
  • 27. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295:1288-1299. 16537739.ArticlePubMed
  • 28. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689. 11315831.ArticlePubMed
  • 29. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-5020. 15472199.ArticlePubMed
  • 30. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214. 10535456.ArticlePubMedPMC
  • 31. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006;21:695-700. 16891815.ArticlePubMedPMC
  • 32. Abel T, Feher J. Effect of moderate alcohol consumption on insulin sensitivity. Orv Hetil 2009;150:2218-2221. 19939782.ArticlePubMed
  • 33. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Nakatani K, et al. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care 2004;27:631-632. 14747267.ArticlePubMed
  • 34. Katsuki A, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Togashi K, et al. Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Endocr J 2005;52:253-257. 15863957.ArticlePubMed
Table 1
General and lifestyle-related characteristics of the subjects with insulin resistance and without insulin resistance by gender
Variables Men
 Women
With insulin resistance (n = 82) Without insulin resistance (n = 516) p With insulin resistance (n=135) Without insulin resistance (n = 537) p
Age 54.5±6.7 54.8±6.9 0.675 54.3±7.2 53.5±7.1 0.241
Family history of type 2 diabetes
 Yes 7 (13.7) 44 (86.3) 0.998 19 (23.5) 62 (76.5) 0.420
 No 75 (13.7) 472 (86.3) 116 (19.6) 475 (80.4)
Education
 <9 51 (11.9) 378 (88.1) 0.042 117 (20.6) 452 (79.4) 0.499
 ≥10 30 (18.3) 134 (81.7) 18 (17.7) 84 (82.4)
Occupation
 Farmer 66 (14.2) 398 (85.8) 0.498 71 (17.5) 334 (82.5) 0.041
 Others 16 (11.9) 118 (88.1) 64 (24.0) 203 (76.0)
Living with spouse
 Yes 41 (15.4) 226 (84.7) 0.294 60 (18.3) 267 (81.7) 0.273
 No 41 (12.4) 290 (87.6) 75 (21.7) 270 (78.3)
Monthly expense (10,000 won)
 <50 17 (16.5) 86 (83.5) 0.598 28 (21.7) 101 (78.3) 0.408
 50-99 20 (11.2) 158 (88.8) 46 (22.3) 160 (77.7)
 100-149 24 (13.4) 155 (86.6) 33 (20.6) 127 (79.4)
 ≥ 150 21 (15.2) 117 (84.8) 28 (15.8) 149 (84.2)
Drinking alcohol
 Non-drinker 29 (15.9) 153 (84.1) 0.275 105 (21.4) 385 (78.6) 0.195
 Ever-drinker 51 (12.6) 243 (87.4) 28 (16.8) 139 (83.2)
Smoking
 Non-smoker 18 (13.4) 116 (86.6) 0.901 134 (20.6) 516 (79.4) 0.310
 Ever-smoker 64 (13.9) 398 (86.1) 1 (5.9) 16 (94.1)
Balanced diet
 Yes 48 (13.4) 311 (86.6) 0.766 79 (22.2) 277 (77.8) 0.149
 No 34 (14.2) 205 (85.8) 56 (17.7) 260 (82.3)
Exercise (sessions/week)
 None or < 3 61 (12.5) 427 (87.5) 0.070 104 (20.0) 415 (80.0) 0.952
 ≥3 21 (19.1) 89 (80.9) 31 (20.3) 122 (79.7)

Data are summarized as a mean±SD or n (%).

Table 2
Clinical characteristics of the subjects with insulin resistance and without insulin resistance by gender
Variables Men
 Women
With insulin resistance (n = 82) Without insulin resistance (n = 516) p With insulin resistance (n = 135) Without insulin resistance (n = 537) p
Body mass index (kg/m2) 23.3±1.3 22.4±1.7 < 0.001 23.1 ±1.4 22.6±1.6 0.001
Waist circumference (cm) 85.0±6.0 80.9±6.3 < 0.001 78.0±5.7 75.9±6.1 0.001
Total cholesterol (mg/dL) 197.9±36.4 186.0±35.7 0.005 204.2 ±34.4 192.8±34.5 0.001
Triglycerides (mg/dL) 171.0 (63.0-372.0) 122.0 (52.0-375.0) 0.083 132.0 (56.0-369.0) 100.0 (46.0-244.0) < 0.001
HDL cholesterol (mg/dL) 51.8±12.3 55.2±14.7 0.026 52.1 ±12.1 56.0±12.7 0.002
LDL cholesterol (mg/dL) 110.2 ± 33.6 102.1 ±35.1 0.056 121.6±30.8 113.7±30.9 0.009
Total cholesterol/HDL cholesterol 4.0±1.1 3.6±1.0 0.001 4.1 ±1.0 3.6±0.9 < 0.001
Triglycerides/HDL cholesterol 3.8±2.4 3.2±3.3 0.061 3.6±3.1 2.3±1.8 < 0.001
Systolic blood pressure (mmHg) 126.8± 15.6 125.2 ± 12.4 0.363 125.5 ± 12.7 123.1 ±13.1 0.053
Diastolic blood pressure (mmHg) 80.6±8.9 79.9±8.0 0.448 79.3±8.1 78.4±8.3 0.241
Fasting glucose (mg/dL) 98.0 (84.0-220.0) 88.0 (73.0-111.0) < 0.001 92.0 (78.0-152.0) 86.0 (76.0-101.0) < 0.001
Fasting insulin (mg/dL) 9.3 (6.3-22.7) 3.4 (1.1-6.8) < 0.001 9.4 (7.1-20.4) 4.4 (1.8-7.4) < 0.001
HOMA-IR 2.3 (1.7-6.2) 0.7 (0.2-1. 6) < 0.001 2.1 (1.7-5.7) 1.0 (0.4-1.6) < 0.001

Data are summarized as a mean±SD, a median (5-95%) or n (%).

HDL high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance.

Table 3
Comparison of metabolic syndrome and its components between the subjects with insulin resistance and without insulin resistance by gender
Variables Men
 Women
With insulin resistance (n = 82) Without insulin resistance (n = 516) p With insulin resistance (n = 135) Without insulin resistance (n = 537) p
Elevated waist circumference (≥90 cm for men and ≥ 85 cm for women) 16 (19.5) 35 (6.8) 0.001 45 (33.3) 122 (22.7) 0.011
Elevated triglycerides (≥ 150 mg/dL) 47 (57.3) 194 (37.6) 0.001 61 (45.2) 124 (23.1) < 0.001
Reduced HDL cholesterol (<40 mg/dL for men and < 50 mg/dL for women) 13 (15.9) 63 (12.2) 0.357 59 (43.7) 196 (36.5) 0.123
Elevated blood pressure* 42 (51.2) 254 (49.2) 0.737 66 (48.9) 228 (42.5) 0.178
Elevated fasting glucose† 37 (45.1) 77 (14.9) < 0.001 39 (28.9) 38 (7.1) < 0.001
Metabolic syndrome* 24 (29.3) 53 (10.3) < 0.001 46 (34.1) 84 (15.6) < 0.001

Data are summarized as N (%).

HDL, high-density lipoprotein.

*Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or antihypertensive medication of previously diagnosed hypertension; †Fasting plasma glucose ≥100 mg/dL or antidiabetic treatment; ‡modified NCEP-ATP III definition.

Table 4
Factors associated with insulin resistance by gender
Variables Men (n = 598)
 Women (n = 672)
Adjusted OR* (95% CI) Adjusted OR* (95% CI)
Age 1.00 (0.97-1.04) 1.01 (0.99-1.05)
BMI (kg/m2) 18.5-20.9 1.00 1.00
21.0-22.9 2.56 (0.94-7.00) 1.35 (0.69-2.66)
23.0-24.9 4.63 (1.77-12.15) 1.89 (0.98-3.56)
High waist circumference Men < 90 cm, Women < 85 cm 1.00 1.00
Men ≥90 cm, Women ≥85 cm 2.57 (1.29-5.11) 1.43 (0.92-2.22)
Education <9 1.00 1.00
≥10 1.54 (0.90-2.64) 0.81 (0.44-1.50)
Occupation Others 1.00 1.00
Farmer 1.31 (0.71-2.41) 0.63 (0.42-1.03)
Drinking alcohol Non-drinker 1.00 1.00
Ever-drinker 0.71 (0.42-1.19) 0.78 (0.49-1.24)
Balanced diet No 1.00 1.00
Yes 0.93 (0.57-1.55) 1.41 (0.92-2.22)
Exercise (sessions/week) None or < 3 1.00 1.00
≥3 1.49 (0.83-2.67) 0.96 (0.60-1.53)

BMI, body mass index; OR, odds ratio; CI, confidence interval.

*Odds ratio adjusted by all other covariates in each variable.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL
      Winde Jorissen, Elien Wouters, Jeroen F. Bogie, Tim Vanmierlo, Jean-Paul Noben, Denis Sviridov, Niels Hellings, Veerle Somers, Roland Valcke, Bart Vanwijmeersch, Piet Stinissen, Monique T. Mulder, Alan T. Remaley, Jerome J. A. Hendriks
      Scientific Reports.2017;[Epub]     CrossRef
    • Insulin Resistance of Normal Weight Central Obese Adolescents in Korea Stratified by Waist to Height Ratio: Results from the Korea National Health and Nutrition Examination Surveys 2008–2010
      Won Kyoung Cho, Hyojin Kim, Hyun Young Lee, Kyung Do Han, Yeon Jin Jeon, In Ah Jung, Shin Hee Kim, Kyoung Soon Cho, So Hyun Park, Min Ho Jung, Byung-Kyu Suh
      International Journal of Endocrinology.2015; 2015: 1.     CrossRef
    • Impact of ENPP1 K121Q on Change of Insulin Resistance after Web-Based Intervention in Korean Men with Diabetes and Impaired Fasting Glucose
      Ji Yeon Kang, Sook Hee Sung, Yeon Ju Lee, Tae In Choi, Seung Jin Choi
      Journal of Korean Medical Science.2014; 29(10): 1353.     CrossRef
    • Genetic determinants of cardiometabolic risk: A proposed model for phenotype association and interaction
      Piers R. Blackett, Dharambir K. Sanghera
      Journal of Clinical Lipidology.2013; 7(1): 65.     CrossRef

    Epidemiol Health : Epidemiology and Health
    © Korean Society of Epidemiology.